ALKS News
Alkermes plc
$39.08
-$0.65(-1.64%)
49
Overall
55
Value
27
Tech
65
Quality
Market Cap
$6.56B
Volume
1.55M
52W Range
$27.00 - $55.67
Target Price
$56.05
ALKS news: the latest Alkermes plc headlines, press releases and market updates, newest first.
Latest ALKS News
- Alkermes (ALKS) Receives a Buy from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Alkermes Advances Adult ADHD Pipeline With New Phase 2 StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 7, 2026
- Alkermes (ALKS) Gets a Hold from Goldman SachsTipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
- Wall Street Analysts Are Neutral on Top Healthcare PicksTipRanks Newsroom · Sep 22, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)TipRanks Newsroom · Sep 22, 2026
- Alkermes Reports Positive Phase 1 ADHD Study ResultsTipRanks Auto-Generated Newsdesk · Sep 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALKS | $39.08 | -1.6% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |